Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate. 2015

Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
Department of Gastroenterology, Suzuka General Hospital, Mie, Japan. hiroki.tanaka@miekosei.or.jp.

A 68-year-old man was referred to our hospital because of left upper quadrant pain. Contrast enhanced computed tomography showed a low density mass with delayed contrast effects as well as para-aortic node swelling with homogenous contrast effects. Histological examination of specimens obtained by endoscopic ultrasound fine needle aspiration revealed a pancreatic neuroendocrine tumor (NET) G2, according to the World Health Organization 2010 classification, and lymph node metastasis. Distal pancreatectomy and lymph node dissection were performed. On histological examination, the tumor showed well-differentiated morphology with an organoid pattern. The Ki67 labeling index was 21.6 %, and the mitotic count was 25/10 high power fields. As mentioned above, we made a final diagnosis of the lesion as "NET G3," because the tumor presented with well-differentiated morphology. Chemotherapy with Everolimus was administered. Liver metastasis occurred 11 months after the first operation, and a partial hepatectomy was performed. Histological findings were similar to those of the first operation. Herein we present a case of pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate referred to as "NET G3," and review the relevant literature.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008940 Mitotic Index An expression of the number of mitoses found in a stated number of cells. Index, Mitotic,Indices, Mitotic,Mitotic Indices
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
August 2019, Current treatment options in oncology,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
January 2018, Histopathology,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
May 2015, The American journal of surgical pathology,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
March 2021, Endocrine pathology,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
January 2020, Cell death and differentiation,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
July 2018, Internal medicine (Tokyo, Japan),
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
April 2018, Pancreas,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
April 2015, La Revue du praticien,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
January 2023, Frontiers in endocrinology,
Hiroki Tanaka, and Shimpei Matsusaki, and Youichirou Baba, and Yoshiaki Isono, and Hiroaki Kumazawa, and Tomohiro Sase, and Hiroshi Okano, and Tomonori Saito, and Katsumi Mukai, and Hiroshi Kaneko
June 2019, Cold Spring Harbor molecular case studies,
Copied contents to your clipboard!